These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32983339)

  • 1. Clinical Evaluation of a Topical Formulation for the Management of Onychomycosis.
    Maggioni D; Cimicata A; Praticò A; Villa R; Bianchi F; Badiale SB; Piana U; Angelinetta C
    J Clin Aesthet Dermatol; 2020 Jul; 13(7):53-57. PubMed ID: 32983339
    [No Abstract]   [Full Text] [Related]  

  • 2. A prospective study using image analysis to assess the efficacy of a topical treatment kit for mild onychomycosis.
    Khammo N; Chesters D; Goldstone L; Kennedy G; Buckley C
    Mycoses; 2020 Feb; 63(2):233-240. PubMed ID: 31595998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An investigation of how fungal infection influences drug penetration through onychomycosis patient's nail plates.
    McAuley WJ; Jones SA; Traynor MJ; Guesné S; Murdan S; Brown MB
    Eur J Pharm Biopharm; 2016 May; 102():178-84. PubMed ID: 26969264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Visible Improvements during K101-03 Treatment: An Open-Label Multicenter Clinical Investigation in Patients with Onychomycosis and/or Nail Psoriasis.
    Piraccini BM; Starace M; Toft A
    Dermatology; 2017; 233(2-3):178-183. PubMed ID: 28787710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Appearance of Nail Polish Following Daily Treatment of Ex Vivo Human Fingernails With Topical Solutions of Tavaborole or Efinaconazole.
    Vlahovic TC; Coronado D; Chanda S; Merchant T; Zane LT
    J Drugs Dermatol; 2016 Jan; 15(1):89-94. PubMed ID: 26741386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daily Application of an Aqueous, Acidifying, Peelable Nail Polish versus Weekly Amorolfine for Topical Onychomycosis Treatment: A Prospective, Randomized, Blinded Trial.
    Eertmans F; Doss N; Rossel B; Adriaens E
    Dermatol Ther (Heidelb); 2018 Sep; 8(3):463-473. PubMed ID: 30051298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Presence of an Air Gap Between the Nail Plate and Nail Bed in Onychomycosis Patients: Treatment Implications for Topical Therapy.
    Gupta AK; Pillai R
    J Drugs Dermatol; 2015 Aug; 14(8):859-63. PubMed ID: 26267730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis.
    Gupta AK; Fleckman P; Baran R
    J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S70-80. PubMed ID: 11051136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,064-nm diode laser therapy of onychomycosis: results of a prospective open treatment of 82 toenails.
    Renner R; Grüsser K; Sticherling M
    Dermatology; 2015; 230(2):128-34. PubMed ID: 25662740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is Severity of Disease a Prognostic Factor for Cure Following Treatment of Onychomycosis?
    Elewski BE; Cantrell W; Lin T
    J Drugs Dermatol; 2018 Feb; 17(2):175-178. PubMed ID: 29462225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tazarotene as alternative topical treatment for onychomycosis.
    Campione E; Paternò EJ; Costanza G; Diluvio L; Carboni I; Marino D; Favalli C; Chimenti S; Bianchi L; Orlandi A
    Drug Des Devel Ther; 2015; 9():879-86. PubMed ID: 25733808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efinaconazole topical solution, 10%: formulation development program of a new topical treatment of toenail onychomycosis.
    Bhatt V; Pillai R
    J Pharm Sci; 2015 Jul; 104(7):2177-82. PubMed ID: 25940933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transungual delivery of ketoconazole using novel lacquer formulation.
    Hafeez F; Hui X; Chiang A; Hornby S; Maibach H
    Int J Pharm; 2013 Nov; 456(2):357-61. PubMed ID: 24029171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of ciclopirox nail lacquer with enhanced permeation and retention.
    Thapa RK; Choi JY; Go TG; Kang MH; Han SD; Jun JH; Son MW; Yong CS; Kim JO
    Arch Pharm Res; 2016 Jul; 39(7):953-9. PubMed ID: 27306785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transungual delivery of efinaconazole: its deposition in the nail of onychomycosis patients and in vitro fungicidal activity in human nails.
    Sakamoto M; Sugimoto N; Kawabata H; Yamakawa E; Kodera N; Pillai R; Tatsumi Y
    J Drugs Dermatol; 2014 Nov; 13(11):1388-92. PubMed ID: 25607707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
    Gupta AK
    J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical application of acidified nitrite to the nail renders it antifungal and causes nitrosation of cysteine groups in the nail plate.
    Finnen MJ; Hennessy A; McLean S; Bisset Y; Mitchell R; Megson IL; Weller R
    Br J Dermatol; 2007 Sep; 157(3):494-500. PubMed ID: 17627796
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Kubota-Ishida N; Takei-Masuda N; Kaneda K; Nagira Y; Chikada T; Nomoto M; Tabata Y; Takahata S; Maebashi K; Hui X; Maibach HI
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Etiopathogenesis, clinical picture and diagnosis of onychomycoses].
    Tasić S; Stojanović S; Poljacki M
    Med Pregl; 2001; 54(1-2):45-51. PubMed ID: 11432322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antifungal Activity of Luliconazole Nail Solution on in vitro and in vivo Onychomycosis Model].
    Shimamura T; Hasegawa N; Kubota N
    Med Mycol J; 2016; 57(1):J13-8. PubMed ID: 26936347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.